Journal article
Abstract 878: Contraceptive use and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers: A prospective cohort study
Abstract
Abstract
Background: Oral contraceptive use is associated with a significantly reduced risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers. To date, there have been no prospective analyses of this relationship, and the impact of other types of contraception (e.g. intrauterine device (IUD), implant, patch, injection) on BRCA-associated ovarian cancer risk is unknown. The goal of this study is to prospectively …
Authors
Xia YY; Lubinski J; Rosen B; Moller P; Eisen A; Ainsworth P; Senter L; Bordeleau L; Neuhausen SL; Singer CF
Journal
Cancer Research, Vol. 81, No. 13_Supplement, pp. 878–878
Publisher
American Association for Cancer Research (AACR)
Publication Date
July 1, 2021
DOI
10.1158/1538-7445.am2021-878
ISSN
0008-5472